Feature Channels: Infectious Diseases

Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 5-Dec-2022 5:00 AM EST Released to reporters: 2-Dec-2022 5:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 5-Dec-2022 5:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 5-Dec-2022 11:00 AM EST Released to reporters: 2-Dec-2022 3:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 5-Dec-2022 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Where did Omicron come from?
Released: 2-Dec-2022 10:50 AM EST
Where did Omicron come from?
Charité - Universitätsmedizin Berlin

First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed.

access_time Embargo lifts in 2 days
This news release is embargoed until 5-Dec-2022 12:00 AM EST Released to reporters: 2-Dec-2022 8:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 5-Dec-2022 12:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 2-Dec-2022 12:15 AM EST Released to reporters: 29-Nov-2022 4:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 2-Dec-2022 12:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 5-Dec-2022 11:00 AM EST Released to reporters: 1-Dec-2022 8:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 5-Dec-2022 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-Dec-2022 7:55 PM EST
Immune T cell defence is coping with COVID-19 variants of concern – for now
University of Birmingham

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

Newswise: Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
Released: 1-Dec-2022 2:30 PM EST
Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
University of North Carolina School of Medicine

SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.

29-Nov-2022 7:55 PM EST
Long COVID patients and those with other illnesses experience similar, negative lingering effects during the pandemic
University of California, Los Angeles (UCLA), Health Sciences

Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses.

Released: 1-Dec-2022 10:05 AM EST
Bruma mental después de la covid: experto de Mayo Clinic describe los signos frecuentes
Mayo Clinic

uando comenzó la pandemia de COVID-19, los pacientes con síndrome de covid prolongada, también conocido como síndrome poscovid, informaron que tenían problemas con el pensamiento. A esto, se ha llegado a conocer como bruma mental y, aunque no sea el término médico oficial, la expresión es ahora una parte permanente de la discusión sobre la covid prolongada. En esta advertencia de un experto, el Dr. Greg Vanichkachorn, director del Programa para rehabilitación de la actividad después de la covid en Mayo Clinic, describe los problemas frecuentes de los pacientes.

Newswise: Flu shots are recommended for those 65 and older as cases rise
Released: 1-Dec-2022 9:05 AM EST
Flu shots are recommended for those 65 and older as cases rise
UT Southwestern Medical Center

With flu cases on the rise, geriatric specialists at UT Southwestern Medical Center say vaccinations are particularly important this year for people 65 and older who are more at risk from complications than other age groups.

Released: 1-Dec-2022 9:00 AM EST
Confusão mental pós-COVID: especialista da Mayo Clinic descreve os sintomas comuns
Mayo Clinic

Nos primeiros dias da pandemia de COVID-19, pacientes com a síndrome da COVID longa (também conhecida como síndrome pós-COVID), relataram problemas de raciocínio. Isso ficou conhecido como confusão ou névoa mental e, embora não seja um termo médico oficial, tornou-se parte permanente da discussão sobre a COVID longa. Neste alerta do especialista, o Dr. Greg Vanichkachorn, M.D., diretor do Programa de Reabilitação de Atividades da COVID da Mayo Clinic, descreve os problemas comuns vivenciados pelos pacientes.

Released: 1-Dec-2022 1:05 AM EST
ضباب الدماغ ما بعد فيروس كورونا المستجد: خبير من مايو كلينك يصف المؤشرات الشائعة
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا— في الأيام الأولى لجائحة فيروس كورونا المستجد (كوفيد-19)، أبلغ المرضى المصابون بمتلازمة فيروس كورونا المستجد طويل الأمد، والمعروفة أيضًا باسم متلازمة ما بعد فيروس كورونا المستجد، عن مشاكل في التفكير. ثم أصبح هذا يُعرف باسم ضباب الدماغ، وعلى الرغم من أنه ليس مصطلحًا طبيًا رسميًا، فقد أصبح جزءًا دائمًا من مناقشات فيروس كورونا المستجد طويل الأمد. وفي هذا المقال، يصف جريج فانيشكاتورن، دكتور الطب، مدير برنامج مايو كلينك لتأهيل النشاط بعد فيروس كورونا المستجد، المشكلات الشائعة التي يعاني منها المرضى.

Released: 30-Nov-2022 6:45 PM EST
Overweight women most likely to suffer long Covid
University of East Anglia

Overweight women are more likely to experience symptoms of long Covid according to new research from the University of East Anglia.

Released: 30-Nov-2022 2:50 PM EST
Scientists did not release a zombie plague by reviving a dormant virus, but their warning of a potential public health crisis is legitimate
Newswise

A team of researchers uncovered an ancient “pandoravirus” from underneath a frozen lake in Siberia. The virus was found along with others in the Siberian permafrost. Scientists say the viruses could help us prepare for pandemic-level issues as the permafrost thaws.

   
Released: 30-Nov-2022 1:05 PM EST
Undernutrition prior to and at treatment initiation for tuberculosis associated with unfavorable outcomes
Boston University School of Medicine

In 2021, an estimated 10.6 million individuals developed tuberculosis (TB) and 1.6 million died, making it the second most lethal infection in the world after SARS-CoV-2.

Released: 30-Nov-2022 1:00 PM EST
Tropic cyclones on the rise in low- and middle- income countries yet remain least studied of climate-related events
Columbia University, Mailman School of Public Health

A new invited perspective from a paper from Columbia University Mailman School of Public Health illustrates the increases in adverse public health outcomes following tropical cyclones, especially in communities with existing health conditions.

Released: 30-Nov-2022 12:40 PM EST
Clover’s vaccine candidate reduced household transmission of SARS-CoV-2 in study
International Vaccine Institute

The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo

Released: 30-Nov-2022 12:35 PM EST
Post-pandemic outbreak of drug-resistant fungus in Brazil owing to abuse of medications and full up ICUs
Fundação de Amparo à Pesquisa do Estado de São Paulo

In Brazil, a group of researchers has reported the largest outbreak to date of COVID-associated candidemia caused by the same drug-resistant strain of Candida parapsilosis, a fungus that invades the bloodstream and can lead to death.

Released: 30-Nov-2022 11:30 AM EST
Research reveals how a potentially fatal COVID-19 complication damages lung tissue
University of Texas Health Science Center at Houston

Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.

Newswise: Researchers developing treatment for drug-resistant fungus with $3M-plus grant from National Institutes of Health
Released: 30-Nov-2022 11:05 AM EST
Researchers developing treatment for drug-resistant fungus with $3M-plus grant from National Institutes of Health
Case Western Reserve University

With a new $3 million-plus grant from the National Institutes of Health (NIH), Case Western Reserve University researchers are examining the next level of treatment for Candida auris (C.auris), a multidrug-resistant yeast that causes serious infection and, in some cases, death.

Newswise:Video Embedded preparing-for-a-tripledemic-holiday-season
VIDEO
Released: 30-Nov-2022 11:00 AM EST
Preparing for a ‘Tripledemic’ Holiday Season
Cedars-Sinai

With COVID-19 and flu cases rising, and RSV (respiratory syncytial virus) affecting many young children, experts are bracing for a “tripledemic” of respiratory viruses this holiday season.

Released: 29-Nov-2022 8:45 PM EST
Engineered proteins: A future treatment option for COVID-19
Texas A&M University

COVID-19 has had a lasting global health impact that continues to challenge the health care system.

   
Newswise: To track disease-carrying mosquitoes, researchers tag them with DNA barcodes
Released: 29-Nov-2022 7:50 PM EST
To track disease-carrying mosquitoes, researchers tag them with DNA barcodes
Colorado State University

West Nile, Zika, dengue and malaria are all diseases spread by bites from infected mosquitoes.

Newswise: COVID-19 vaccine’s effectiveness diminishes with age, research shows
Released: 29-Nov-2022 4:00 PM EST
COVID-19 vaccine’s effectiveness diminishes with age, research shows
UT Southwestern Medical Center

The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.

Released: 29-Nov-2022 2:50 PM EST
Adapting language models to track virus variants
Argonne National Laboratory

Groundbreaking research by Argonne National Laboratory finds new method to quickly identify COVID-19 virus variants. Their work wins the Gordon Bell Special Prize.

21-Nov-2022 2:05 PM EST
Despite fewer overall COVID-19 deaths, more younger people died in second year of the pandemic
American College of Physicians (ACP)

A brief research report found that despite 20.8 percent fewer COVID-19 deaths occurring in the second year of the COVID-19 pandemic, 7.4 percent more years of life were lost due to a shift in COVID-19 mortality to relatively younger people. The report is published in Annals of Internal Medicine.

21-Nov-2022 2:05 PM EST
In some settings, medical masks may offer similar effectiveness to N95 respirators for preventing COVID-19 infection among health care workers
American College of Physicians (ACP)

A study of more than 1,000 health care workers was unable to establish whether medical masks are significantly less effective at preventing COVID-19 infection than N95 respirators in hospital settings. The findings varied across countries, which were studied during different times in the pandemic, and uncertainty in the estimates of effect limit definitiveness of findings. The study is published in Annals of Internal Medicine.

21-Nov-2022 2:05 PM EST
Critical changes in COVID-19 standards of care associated with improved mortality outcomes
American College of Physicians (ACP)

An observational study of COVID-19 standard of care (SOC) measures found improvements in recovery and mortality over time in adults hospitalized with COVID-19 and investigated changes in SOC that may explain these improvements. The study is published in Annals of Internal Medicine.

Released: 28-Nov-2022 12:55 PM EST
Community pharmacy-led vaccination scheme helped thousands of patients overcome hesitancy around Covid-19 jabs, research finds
Kingston University

An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by an expert from Kingston University has shown.

Newswise: Dr. Fauci reflects on the perpetual challenge of infectious diseases
Released: 28-Nov-2022 12:20 PM EST
Dr. Fauci reflects on the perpetual challenge of infectious diseases
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in The New England Journal of Medicine.

Released: 28-Nov-2022 12:05 PM EST
Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy
Infectious Diseases Data Observatory (IDDO)

A new WWARN meta-analysis commissioned by the World Health Organization (WHO) which informed a change to its treatment guidelines* has been published in The Lancet.

27-Nov-2022 9:05 AM EST
Gut Microbes Disturbed by COVID-19 Infection, Especially with Antibiotics
Rutgers University-New Brunswick

In an intensive look at the effects of the virus causing COVID-19 on patients’ microbiome – the collection of microorganisms that live in and on the human body – Rutgers scientists found that acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment.

Released: 28-Nov-2022 9:00 AM EST
Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection
Sbarro Health Research Organization (SHRO)

Researchers working with Sbarro Health Research Organization (SHRO) have published a paper examining the possible links between neurological involvement and respiratory damage due to COVID-19.

Newswise: Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment
Released: 23-Nov-2022 2:00 PM EST
Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment
University of Bristol

Researchers of the University of Bristol-led study, published in Science Advances today [23 November], say their findings could lead to the development of a pan-coronavirus treatment to defeat all coronaviruses.

Released: 23-Nov-2022 10:55 AM EST
Scientists discover new mechanism associated with severe COVID-19
Fundação de Amparo à Pesquisa do Estado de São Paulo

Researchers at the University of São Paulo (USP) in Brazil have found that severe COVID-19 is associated with an imbalance in an important immune system signaling pathway.

Released: 22-Nov-2022 7:55 PM EST
Fear of COVID-19 continues to impact adversely on psychological wellbeing
Swansea University

Research by psychologists from the School of Psychology at Swansea University found that people’s fear of COVID-19 has led to worsened mental health.

Newswise: Remdesivir reduces COVID-19 mortality in a real-world setting
Released: 22-Nov-2022 7:45 PM EST
Remdesivir reduces COVID-19 mortality in a real-world setting
Tokyo Medical and Dental University

The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial.

Released: 22-Nov-2022 5:00 PM EST
World’s heaviest bird may be self-medicating on plants used in traditional medicine
Frontiers

Researchers show that great bustards in Spain prefer to eat two plant species with compounds active in vitro against protozoa, nematodes, and fungi: corn poppies and purple viper’s bugloss. Males, who spend much time and energy on sexual displays during the mating season, have a stronger preference for these plants than females, and more so during the mating season than at other times of the year. The authors thus consider great bustards as prime candidates for non-human animals that self-medicate, but stress that more research is needed to definitively prove this.

Released: 22-Nov-2022 2:35 PM EST
A growing trend of antibody evasion by new omicron subvariants
Ohio State University

Three currently circulating omicron subvariants of SARS-CoV-2 – including two that currently make up almost 50% of reported COVID-19 infections in the U.S. – are better at evading vaccine- and infection-generated neutralizing antibodies than earlier versions of omicron, new research suggests.

21-Nov-2022 10:05 AM EST
COVID-19 vaccine gives substantial protection against reinfection
PLOS

Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup Nielsen at Statens Serum Institut, Denmark, reports these findings November 22nd in the open access journal PLOS Medicine.

Released: 22-Nov-2022 12:10 PM EST
First evidence drug resistant bacteria can travel from gut to lung, increasing infection risks
University of Oxford

A new study released today in Nature Communications from the Department of Biology, University of Oxford has found the first direct evidence of antibiotic resistant bacteria migrating from a patient’s gut microbiome to the lungs.

Released: 22-Nov-2022 12:05 PM EST
WHO-recommended hand disinfectants inactivate monkeypox viruses
Ruhr-Universität Bochum

Alcohol-based disinfectants are effective against enveloped viruses.

Newswise: NIH establishes website for self-reporting COVID-19 test results
Released: 22-Nov-2022 12:00 PM EST
NIH establishes website for self-reporting COVID-19 test results
National Institute of Biomedical Imaging and Bioengineering

Reporting a positive or negative test result just became easier through a new website from the National Institutes of Health. MakeMyTestCount.org, developed through NIH’s Rapid Acceleration of Diagnostics (RADx®) Tech program, allows users to anonymously report the results of any brand of at-home COVID-19 test.

Newswise: HIV Infection Leaves a ‘Memory’ in Cells
Released: 22-Nov-2022 11:25 AM EST
HIV Infection Leaves a ‘Memory’ in Cells
George Washington University

Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of their lives.

Newswise: The Interplay Between Epidemics, Prevention Information, and Mass Media
16-Nov-2022 10:25 AM EST
The Interplay Between Epidemics, Prevention Information, and Mass Media
American Institute of Physics (AIP)

When an epidemic strikes, more than just infections spread. As cases mount, information about the disease, how to spot it, and how to prevent it propagates rapidly among people in affected areas as well.

   
17-Nov-2022 7:05 AM EST
Physicians urged to consider fungal infections as possible cause for lung inflammation
UC Davis Health

UC Davis Health infectious diseases expert George Thompson warns of the rising threat and apparent spread of disease-causing fungi outside their traditional hot spots. Fungal lung infections are commonly misdiagnosed, leading to delays in treatment and increase in antimicrobial resistance in the community.

   
Newswise: Mapping Lyme disease out west
Released: 21-Nov-2022 2:50 PM EST
Mapping Lyme disease out west
University of California, Santa Barbara

Tick bites transmit Lyme disease. But even knowing where these ticks live doesn’t necessarily mean you can predict the disease in humans.

   
Newswise: Study shows superbugs in the environment rarely transfer over to humans: Hospitals are more risky than farms
Released: 21-Nov-2022 2:40 PM EST
Study shows superbugs in the environment rarely transfer over to humans: Hospitals are more risky than farms
University of Bath

An international team of scientists investigating transmission of a deadly drug resistant bacteria that rivals MRSA, has found that whilst the bugs are found in livestock, pets and the wider environment, they are rarely transmitted to humans through this route.

   

Showing results

150 of 11228

close
2.55788